Neostigmine
FDA Announces Import of Injectable Nutrition Drugs »
"The U.S. Food and Drug Administration announced today that injectable drugs used in total parenteral nutrition (TPN) in critical shortage will be imported into the United States and available to patients this week.
TPN is an intravenous"...
Read the FDA Announces Import of Injectable Nutrition Drugs article »
Neostigmine Methylsulfate
Neostigmine Methylsulfate (neostigmine methylsulfate (neostigmine methylsulfate injection) injection)
Injection, USP
DRUG DESCRIPTION
Neostigmine Methylsulfate Injection, USP is the dimethylcarbamate of (m-hydroxyphenyl) trimethylammonium methylsulfate.
The structural formula is:
 |
C13H22N2O6S............................Molecular Weight 334.40
Neostigmine Methylsulfate (neostigmine methylsulfate (neostigmine methylsulfate injection) injection) , an anticholinesterase agent, is a bitter tasting, white crystalline powder and is very soluble in water and soluble in alcohol. Neostigmine Methylsulfate (neostigmine methylsulfate (neostigmine methylsulfate injection) injection) Injection, USP is a sterile, nonpyrogenic solution intended for intramuscular, subcutaneous or slow intravenous use.
Each mL of the 1:1000 concentration contains Neostigmine Methylsulfate (neostigmine methylsulfate (neostigmine methylsulfate injection) injection) 1 mg, Methylparaben 1.8 mg and Propylparaben 0.2 mg (used as preservatives), in Water for Injection q.s.pH (range 5.0 - 6.5) adjusted, when necessary, with Sodium Hydroxide.
Each mL of the 1:2000 concentration contains Neostigmine Methylsulfate (neostigmine methylsulfate (neostigmine methylsulfate injection) injection) 0.5 mg, Methylparaben 1.8 mg and Propylparaben 0.2 mg (used as preservatives), in Water for Injection q.s.pH (range 5.0 - 6.5) adjusted, when necessary, with Sodium Hydroxide.
Last reviewed on RxList: 6/26/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Neostigmine Methylsulfate Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
